MCIDAS
Basic information
Region (hg38): 5:55219564-55227315
Previous symbols: [ "MCIN" ]
Links
Phenotypes
GenCC
Source:
- ciliary dyskinesia, primary, 42 (Strong), mode of inheritance: AR
- ciliary dyskinesia, primary, 42 (Moderate), mode of inheritance: AR
- ciliary dyskinesia, primary, 42 (Strong), mode of inheritance: AR
- primary ciliary dyskinesia (Supportive), mode of inheritance: AD
- ciliary dyskinesia, primary, 42 (Definitive), mode of inheritance: AR
Clinical Genomic Database
Source:
Condition | Inheritance | Intervention Categories | Intervention/Rationale | Manifestation Categories | References |
---|---|---|---|---|---|
Ciliary dyskinesia, primary, 42 | AR | Allergy/Immunology/Infectious; Pulmonary | Pulmonary surveillance may be beneficial to assess respiratory function and institute early management measures; In order to facilitate mucus clearance, aggressive interventions (eg, chest percussion and oscillatory vest), as well as vaccinations and early and aggressive treatment of respiratory infections may be beneficial, though measures including lobectomy or lung transplantation may be necessary | Allergy/Immunology/Infectious; Neurologic; Pulmonary | 25048963; 30237576 |
ClinVar
This is a list of variants' phenotypes submitted to
- Primary ciliary dyskinesia (5 variants)
- not provided (1 variants)
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the MCIDAS gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 53 | 56 | ||||
missense | 62 | 67 | ||||
nonsense | 2 | |||||
start loss | 0 | |||||
frameshift | 5 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 2 | |||||
splice region | 1 | 15 | 16 | |||
non coding | 14 | 22 | ||||
Total | 6 | 3 | 64 | 71 | 10 |
Variants in MCIDAS
This is a list of pathogenic ClinVar variants found in the MCIDAS region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
5-55220230-A-T | Benign (Nov 12, 2018) | |||
5-55220358-A-G | Benign (May 05, 2021) | |||
5-55220370-C-A | Primary ciliary dyskinesia | Uncertain significance (May 13, 2021) | ||
5-55220373-G-T | Primary ciliary dyskinesia | Uncertain significance (Aug 22, 2022) | ||
5-55220382-C-T | Ciliary dyskinesia, primary, 42 • Primary ciliary dyskinesia | Likely pathogenic (Jun 27, 2022) | ||
5-55220387-C-G | Inborn genetic diseases | Uncertain significance (Jan 31, 2023) | ||
5-55220399-G-A | Primary ciliary dyskinesia | Likely benign (Aug 14, 2023) | ||
5-55220407-T-C | Inborn genetic diseases | Uncertain significance (Dec 19, 2022) | ||
5-55220427-C-T | Ciliary dyskinesia, primary, 42 | Pathogenic (Dec 13, 2019) | ||
5-55220433-G-C | Primary ciliary dyskinesia | Uncertain significance (Jun 04, 2022) | ||
5-55220439-G-A | Primary ciliary dyskinesia | Uncertain significance (Dec 20, 2023) | ||
5-55220448-C-A | Primary ciliary dyskinesia | Uncertain significance (Mar 27, 2018) | ||
5-55220462-G-A | Primary ciliary dyskinesia | Likely benign (Jan 15, 2024) | ||
5-55220469-A-T | Inborn genetic diseases | Uncertain significance (Nov 21, 2023) | ||
5-55220470-T-G | Primary ciliary dyskinesia | Uncertain significance (Jan 16, 2018) | ||
5-55220471-G-A | Primary ciliary dyskinesia | Likely benign (Jul 17, 2023) | ||
5-55220474-G-C | Primary ciliary dyskinesia • MCIDAS-related disorder | Likely benign (Oct 28, 2023) | ||
5-55220477-G-A | Primary ciliary dyskinesia | Likely benign (Aug 14, 2023) | ||
5-55220484-G-A | Primary ciliary dyskinesia • Inborn genetic diseases • Ciliary dyskinesia, primary, 42 | Uncertain significance (Nov 08, 2022) | ||
5-55220488-C-T | Inborn genetic diseases | Uncertain significance (Feb 14, 2024) | ||
5-55220492-C-T | Primary ciliary dyskinesia | Likely benign (Jul 08, 2020) | ||
5-55220520-A-T | Primary ciliary dyskinesia | Pathogenic/Likely pathogenic (Jan 02, 2024) | ||
5-55220521-A-G | Likely benign (Sep 02, 2017) | |||
5-55220523-G-C | Primary ciliary dyskinesia | Uncertain significance (Jan 15, 2020) | ||
5-55220525-G-T | Inborn genetic diseases | Likely benign (Sep 25, 2023) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
MCIDAS | protein_coding | protein_coding | ENST00000513312 | 7 | 7702 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.0133 | 0.958 | 0 | 0 | 0 | 0 | 0.00 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 1.88 | 126 | 201 | 0.626 | 0.00000949 | 2472 |
Missense in Polyphen | 43 | 66.972 | 0.64206 | 835 | ||
Synonymous | 1.50 | 72 | 90.1 | 0.799 | 0.00000441 | 819 |
Loss of Function | 1.90 | 5 | 12.2 | 0.411 | 5.27e-7 | 161 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.00 | 0.00 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.00 | 0.00 |
Finnish | 0.00 | 0.00 |
European (Non-Finnish) | 0.00 | 0.00 |
Middle Eastern | 0.00 | 0.00 |
South Asian | 0.00 | 0.00 |
Other | 0.00 | 0.00 |
dbNSFP
Source:
- Function
- FUNCTION: Transcription regulator specifically required for multiciliate cell differentiation. Acts in a multiprotein complex containing E2F4 and E2F5 that binds and activates genes required for centriole biogenesis. Required for the deuterosome-mediated acentriolar pathway (PubMed:25048963). Plays a role in mitotic cell cycle progression by promoting cell cycle exit. Modulates GMNN activity by reducing its affinity for CDT1 (PubMed:21543332, PubMed:24064211). {ECO:0000250|UniProtKB:Q08B36, ECO:0000269|PubMed:21543332, ECO:0000269|PubMed:24064211, ECO:0000269|PubMed:25048963}.;
Haploinsufficiency Scores
- pHI
- hipred
- hipred_score
- ghis
- 0.396
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- gene_indispensability_score
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Mcidas
- Phenotype
Gene ontology
- Biological process
- regulation of DNA replication;cell cycle;regulation of mitotic cell cycle;motile cilium assembly;positive regulation of transcription by RNA polymerase II;cilium assembly;centriole assembly;multi-ciliated epithelial cell differentiation
- Cellular component
- nucleus;nucleolus;nuclear body
- Molecular function
- transcription coactivator activity;protein binding;identical protein binding